Earnings Feed
Start Free
INTEST CORP·4

Mar 18, 5:02 PM ET

Grant Richard N. Jr. 4

4 · INTEST CORP · Filed Mar 18, 2026

Research Summary

AI-generated summary of this filing

Updated

InTest (INTT) CEO Richard Grant Sells 1,636 Shares

What Happened
Richard N. Grant Jr., President, CEO and Director of InTest Corporation, reported a small open‑market sale and several grant transactions. On 2026-03-18 he sold 1,636 shares at a weighted average price of $14.28 for proceeds of $23,360. On 2026-03-16 he was granted restricted/derivative awards totaling 51,009 shares (two grants of 13,822 shares and one 23,365-share award) at $0.00 per share as compensation under the InTest 2023 Stock Incentive Plan.

Key Details

  • Sale: 2026-03-18 — 1,636 shares disposed; weighted average price reported $14.28 (sales executed in multiple trades at $14.25–$14.425). Total cash received ~ $23,360. (Footnotes F3, F4)
  • Grants: 2026-03-16 — grants reported as acquired at $0.00 (total shown = 51,009 shares). Some grants are time-based and some performance‑based. (Footnotes F1, F2)
  • Vesting: Time-based restricted shares vest in four equal annual installments beginning March 16, 2027 (F1). Performance-based restricted shares vest in March 2029 subject to performance criteria; the filing shows target amounts and notes a maximum that may vest. (F2)
  • Sale reason and mechanics: The shares sold were to satisfy tax withholding in connection with vesting and were effected under a Rule 10b5-1 trading plan adopted Dec 8, 2023 (F3). The filer offers to provide per‑price breakdown on request (F4).
  • Options/other notes: The filing includes footnotes about option vesting schedules (F5–F9) though no option exercise or option proceeds are listed in these transactions.
  • Shares owned after transaction: Not specified in the supplied transaction summary / Form 4 excerpt.
  • Timeliness: Form 4 filed 2026-03-18 for transactions on 2026-03-16–03-18; no late filing flag indicated.

Context
The March 18 sale appears to be a routine tax‑withholding sale carried out under a pre-established 10b5‑1 plan, which is common when restricted stock vests and does not necessarily signal the insider’s market view. The March 16 entries are compensation grants (time‑based and performance‑based) that will vest later if time and/or performance conditions are met; such awards are standard executive compensation.

Insider Transaction Report

Form 4
Period: 2026-03-16
INTEST CORPINTT
Grant Richard N. Jr.
DirectorPresident & CEO
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-16+13,822→ 200,544 total
  • Award

    Common Stock

    [F2]
    2026-03-16+13,822→ 214,366 total
  • Sale

    Common Stock

    [F3][F4]
    2026-03-18$14.28/sh−1,636$23,360→ 212,730 total
  • Award

    Employee Stock Option (right to buy)

    [F5]
    2026-03-16+23,365→ 23,365 total
    Exercise: $14.47Exp: 2036-03-15→ Common Stock (23,365 underlying)
Holdings

  • Employee Stock Option (right to buy)

    [F6]
    Exercise: $7.74Exp: 2035-03-16→ Common Stock (2,327 underlying)
    2,327

  • Employee Stock Option (right to buy)

    [F6]
    Exercise: $7.74Exp: 2035-03-16→ Common Stock (43,384 underlying)
    43,384

  • Employee Stock Option (right to buy)

    [F7]
    Exercise: $11.33Exp: 2034-03-05→ Common Stock (30,536 underlying)
    30,536

  • Employee Stock Option (right to buy)

    [F8]
    Exercise: $16.06Exp: 2033-03-07→ Common Stock (16,988 underlying)
    16,988

  • Employee Stock Option (right to buy)

    [F9]
    Exercise: $9.76Exp: 2032-03-08→ Common Stock (25,692 underlying)
    25,692

  • Employee Stock Option (right to buy)

    [F9]
    Exercise: $10.62Exp: 2031-03-09→ Common Stock (112,000 underlying)
    112,000
Footnotes (9)
  • [F1]These restricted shares were granted pursuant to the InTest Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027.
  • [F2]These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in March 2029 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 20,733.
  • [F3]Shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.25 to $14.425, inclusive. The reporting person undertakes to provide InTest Corporation, any security holder of InTest Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027.
  • [F6]This option vests in four equal annual installments commencing on March 17, 2026.
  • [F7]This option vests in four equal annual installments commencing on March 6, 2025.
  • [F8]This option vests in four equal annual installments commencing on March 8, 2024.
  • [F9]This option is fully vested as of the date of this report.
Signature
/s/ Duncan Gilmour, Attorney-in-Fact for Richard N. Grant, Jr.|2026-03-18

Documents

2 files
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

  • EX-24.1
    exhibit24-1.txt

    GRANT POA